Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 13876 record(s)

Req # A-2020-001783

All presentation material including background material, and proposed warnings for all tobacco products presented by the Tobacco Control Directorate team to stakeholders during the consultation or virtual meeting on February 17, 2021.

Organization: Health Canada

45 page(s)
March 2021

Req # A-2020-001791

The number of emails received by the Minister of Health (either addressed directly to the Minister or copied to the Minister) through email address hcminister.ministresc@canada.ca concerning the treatment of wood with chromated copper arsenate (CCA…

Organization: Health Canada

1 page(s)
March 2021

Req # A-2016-000988

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 16-105493-187, Vanessa's Law Implementation.

Organization: Health Canada

15 page(s)
March 2021

Req # A-2019-001709

Adverse Drug Reaction (ADR) for Amphetamine aspartate. Report number: E2B_02675074.

Organization: Health Canada

26 page(s)
March 2021

Req # A-2020-000197

Adverse Drug Reaction (ADR). Report number: E2B_02610584.

Organization: Health Canada

16 page(s)
March 2021

Req # A-2020-000251

Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02796933, E2B_02753830, E2B_02794433.

Organization: Health Canada

68 page(s)
March 2021

Req # A-2020-000326

Adverse Reaction Reports (AERs) for Mezavant. Report numbers: E2B_02825035, E2B_02882429, E2B_02907794, E2B_02913170, E2B_02913375, E2B_02973212, E2B_02959658, E2B_02955630, E2B_02955280, E2B_02944188, E2B_02933965, E2B_02931008, E2B_02925932.

Organization: Health Canada

146 page(s)
March 2021

Req # A-2020-000364

Adverse Drug Reaction (ADR) for TERIFLUNOMIDE. Report number: E2B_02791526.

Organization: Health Canada

12 page(s)
March 2021

Req # A-2020-000592

Adverse Drug Reaction (ADR) for Botulinum toxin type A. Report number: E2B_03136030.

Organization: Health Canada

8 page(s)
March 2021

Req # A-2020-000889

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-110509-318, Laboratories Canada Overview.

Organization: Health Canada

17 page(s)
March 2021
Date modified: